Shopping Cart
Remove All
Your shopping cart is currently empty
Gavilimomab (ABX-CBL) is a murine-derived IgM monoclonal antibody against CD147 antigen used in immunosuppressive biologic treatments for glucocorticoid-resistant graft-versus-host disease (GVHD).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $1,089 | - | In Stock | |
| 5 mg | $2,389 | - | In Stock | |
| 10 mg | $3,578 | 4-6 weeks | 4-6 weeks |
| Description | Gavilimomab (ABX-CBL) is a murine-derived IgM monoclonal antibody against CD147 antigen used in immunosuppressive biologic treatments for glucocorticoid-resistant graft-versus-host disease (GVHD). |
| Synonyms | CBL-1, ABX-CBL, ABXCBL |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CD147/Basigin |
| Molecular Weight | 0 |
| Cas No. | 244096-20-6 |
| Isotype | Mouse IgM |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.